

A provider's guide to helping patients find Natamycin (Natacyn) in stock. Practical workflows, alternative options, and tools for eye care teams.
You've diagnosed fungal keratitis, prescribed Natamycin (Natacyn 5% ophthalmic suspension), and now your patient calls back: their pharmacy doesn't have it. This scenario is all too familiar for ophthalmologists and eye care providers across the country.
Natamycin is the only FDA-approved topical antifungal eye drop in the United States, yet it's one of the hardest ophthalmic medications for patients to obtain. As a provider, you're uniquely positioned to help bridge this gap. This guide outlines practical, actionable steps your practice can take to ensure patients get timely access to Natamycin.
As of 2026, Natamycin is not on the FDA Drug Shortage list, meaning Alcon Laboratories is actively manufacturing and distributing Natacyn. However, practical availability remains limited at the pharmacy level:
For the latest supply information, see our provider shortage briefing.
Understanding the barriers your patients face helps you design better access workflows:
Fungal eye infections represent a tiny fraction of ophthalmic prescriptions. Pharmacies stock based on demand, and Natamycin simply doesn't generate enough volume at any single location to justify shelf space.
Natacyn is primarily distributed through specialty channels. Many standard pharmacy wholesalers carry limited quantities or require special ordering, adding one to two business days to fulfillment.
Prior authorization requirements, specialty tier placement, and high copays create additional delays. Patients may arrive at the pharmacy only to learn their insurance requires paperwork that hasn't been completed.
Many patients don't understand why a "simple eye drop" is so hard to find. They may try one pharmacy, get discouraged, and delay treatment — which can have serious consequences for fungal keratitis outcomes.
The single most effective step is identifying one or two specialty pharmacies that reliably stock Natamycin and establishing them as your practice's preferred dispensing partners. Options include:
Once you have a preferred pharmacy, send Natamycin prescriptions there by default rather than leaving it to the patient's usual retail pharmacy.
Medfinder for Providers allows your team to quickly search for pharmacies with Natamycin in stock by location. This can be done at the point of prescribing, before the patient even leaves your office. Integrating a Medfinder check into your workflow takes seconds and can save patients hours of frustration.
Don't wait for the pharmacy to trigger the prior authorization process. Instead:
If your practice treats fungal keratitis with any regularity, consider maintaining a small clinic inventory of Natacyn. Even one or two bottles can serve as bridge therapy while the patient's prescription is being processed through a pharmacy. Check with your state pharmacy board regarding regulations for office dispensing.
Establish a relationship with a compounding pharmacy that can prepare antifungal ophthalmic solutions on short notice. The most commonly compounded alternatives include:
Having a compounding pharmacy on standby means you can initiate alternative therapy within hours if Natamycin cannot be obtained in time.
When Natamycin is unavailable or a patient cannot afford it, the following alternatives should be considered based on the specific clinical scenario:
Direct patients to our resource on alternatives to Natamycin for additional patient-facing information.
Here are additional practical tips to streamline Natamycin access for your patients:
Develop a written protocol for your clinical staff that outlines the steps to follow whenever Natamycin is prescribed:
Set expectations upfront. Tell patients:
Keep a simple log of Natamycin prescriptions, fill times, and any access issues. This data can help you refine your workflow, identify the most reliable pharmacies, and build a case for stocking the medication in-house.
Natamycin access is a known challenge in ophthalmology, but it's a solvable one. Providers who build proactive workflows — establishing specialty pharmacy partnerships, leveraging tools like Medfinder, managing prior authorization aggressively, and maintaining compounding pharmacy relationships — can dramatically reduce the time it takes for their patients to start treatment.
Fungal keratitis outcomes depend on timely therapy. By taking these steps, you're not just solving a logistics problem — you're protecting your patients' vision.
For the latest supply updates, see our Natamycin shortage briefing for providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.